REQUEST A DEMO
Total
USD $0.00
Search more companies

Apta Medica Internacional D.o.o. (Slovenia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Apta Medica Internacional D.o.o. Profile Updated: November 04, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Apta Medica Internacional D.o.o is a pharmaceutical company specializing in drug registration, marketing, and wholesale activities. The company distributes its own medicinal products under the brand AptaPharma, as well as products on behalf of their partners. Founded by private and corporate founders with a long tradition in the health sector, the company is committed to continuously expanding its product portfolio in the pharmaceutical market.

Headquarters
6 Likozarjeva Street
Ljubljana; Osrednjeslovenska; Postal Code: 1000

Contact Details: Purchase the Apta Medica Internacional D.o.o. report to view the information.

Website: http://www.apta-medica.com

Basic Information
Total Employees:
Purchase the Apta Medica Internacional D.o.o. report to view the information.
Registered Capital:
Purchase the Apta Medica Internacional D.o.o. report to view the information.
Financial Auditors:
Purchase the Apta Medica Internacional D.o.o. report to view the information.
Incorporation Date:
January 16, 2026
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Procurator
Purchase this report to view the information.
Procurator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Apta Medica Internacional D.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
18.8%
Total operating revenue
18.76%
Operating profit (EBIT)
43.58%
EBITDA
32.7%
Net Profit (Loss) for the Period
31.61%
Total Assets
20.01%
Total Equity
8.71%
Operating Profit Margin (ROS)
2.85%
Net Profit Margin
1.21%
Return on Equity (ROE)
5.95%
Debt/Equity
15.76%
Quick Ratio
-2.38%
Cash Ratio
-0.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?